Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.11.5817

Association Between GSTM1 Polymorphism and Nasopharyngeal Cancer Susceptibility: a Meta-analysis  

Sun, Zhen-Feng (Department of Otorhinolaryngology, Shanghai First People's Hospital)
Zhang, Jia (Department of Otorhinolaryngology, Shanghai First People's Hospital)
Xu, Hong-Ming (Department of Otorhinolaryngology, Shanghai First People's Hospital)
Wang, Guo-Liang (Department of Otorhinolaryngology, Shanghai First People's Hospital)
Dong, Pin (Department of Otorhinolaryngology, Shanghai First People's Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.11, 2012 , pp. 5817-5821 More about this Journal
Abstract
Background/Aims: Glutathione S-transferase M1 (GSTM1) is a multifunctional enzyme that plays a critical role in the detoxification of varieties of carcinogenic metabolites. Many studies have been conducted to investigate the association between GSTM1 polymorphism and nasopharyngeal cancer (NPC) risk, but the findings among those studies are inconsistent. To assess this relationship more precisely, we performed a meta-analysis of all available studies on the subject. Methods: Case-control studies were identified by searching Pubmed, Embase, ISI Web of Science, and Wanfang databases through September 6, 2012. We used the pooled odds ratio (OR) with its corresponding 95% confidence interval (95%CI) to evaluate the association of GSTM1 polymorphism with NPC susceptibility. Subgroup analyses by pathological types, sex and smoking status were performed to further identify the association. Results: Overall, 11 published studies with 1,513 cases and 2,802 controls were finally included into this meta-analysis according to the inclusion criteria. Meta-analysis of total studies showed that the null genotype of GSTM1 was significantly associated with increased risk of NPC, when comparing with the non-null genotype (OR=1.51, 95%CI=1.33-1.72, POR<0.001). The association was still statistically significant in subgroup analysis of patients with nasopharyngeal squamous cell carcinoma (OR=1.73, 95%CI=1.24-2.42, POR=0.001). Males with the null genotype of GSTM1 were more likely to subject to NPC than females. In addition, the association between the null genotype of GSTM1 and NPC risk was strongest in individuals with exposure to smoking. Sensitivity analysis by sequential omission of any individual studies one at a time further demonstrated the significant association. Conclusions: The findings suggest that the null genotype of GSTM1 is a risk factor for NPC, and there is a gene-smoking interaction in this association.
Keywords
Nasopharyngeal cancer; polymorphism; glutathione S-transferase M1; meta-analysis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ahmad ST, Arjumand W, Seth A, et al (2012). Impact of glutathione transferase M1, T1, and P1 gene polymorphisms in the genetic susceptibility of North Indian population to renal cell carcinoma. DNA Cell Biol, 31, 636-43.   DOI
2 Attia J, Thakkinstian A, D'Este C (2003). Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol, 56, 297-303.   DOI
3 Bendjemana K, Abdennebi M, Gara S, et al (2006). Genetic polymorphism of gluthation-S transferases and N-acetyl transferases 2 and nasopharyngeal carcinoma: the Tunisia experience. Bull Cancer, 93, 297-302.
4 Chan AT (2011). Current treatment of nasopharyngeal carcinoma. Eur J Cancer, 47, S302-3.
5 Chang ET, Adami HO (2006). The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 15, 1765-77.   DOI
6 Cheng YJ, Chien YC, Hildesheim A, et al (2003). No association between genetic polymorphisms of CYP1A1, GSTM1, GSTT1, GSTP1, NAT2, and nasopharyngeal carcinoma in Taiwan. Cancer Epidemiol Biomarkers Prev, 12, 179-80.
7 Cochran WG (1950). The comparison of percentages in matched samples. Biometrika, 37, 256-66.   DOI
8 Da SJ, Liang B, Wu HL, et al (2002). Relationship between GSTM1 gene polymorphism and genetic susceptibility in nasopharyngeal carcinoma. Prac J Cancer, 17, 617-26 (in Chinese).
9 Deng ZL, Wei YP, Luo W, et al (2005). Glutathione S-transferase M1 and T1 gene deletion associated with increased susceptibility to nasopharyngeal carcinoma. Chin German J Clini Onc, 4, 276-8.   DOI
10 Deng ZL, Wei YP, Ma Y (2004). Frequent genetic deletion of detoxifying enzyme GSTM1 and GSTT1 genes in nasopharyngeal carcinoma patients in Guangxi Province, China. Zhonghua Zhong Liu Za Zhi, 26, 598-600 (in Chinese).
11 DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.   DOI
12 Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.   DOI
13 Guo X, O'Brien SJ, Zeng Y, et al (2008). GSTM1 and GSTT1 gene deletions and the risk for nasopharyngeal carcinoma in Han Chinese. Cancer Epidemiol Biomarkers Prev, 17, 1760-3.   DOI
14 Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.   DOI   ScienceOn
15 Ho CK, Lo W CH, Huang PH (1999). Suspected nasopharyngeal carcinoma in three workers with long term exposure to sulphuric acid vapour. Occup Environ Med, 56, 426-8.   DOI
16 Jiang Y, Li N, Dong P, et al (2011). Polymorphisms in GSTM1, GSTTI and GSTP1 and nasopharyngeal cancer in the east of China: a case-control study. Asian Pac J Cancer Prev, 12, 3097-100.
17 Liu ZG, Wei YP, Ma Y, et al (2003). Population with GSTT1 gene deletion and the relationship to hepatocellular caecinoma from Guangxi. J Guangxi Med Univ, 20, 161-3 (in Chinese).
18 Mantel N ,Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
19 Md A, J W, A T, et al (1999). Facial artery and atherosclerosis. Folia Morphol (Warsz), 58, 199-206.
20 Moaven O, Raziee HR, Sima HR, et al (2010). Interactions between Glutathione-S-Transferase M1, T1 and P1 polymorphisms and smoking, and increased susceptibility to esophageal squamous cell carcinoma. Cancer Epidemiol, 34, 285-90.   DOI
21 Nazar-Stewart V, Vaughan TL, Burt RD, et al (1999). Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev, 8, 547-51.
22 Vrana D, Pikhart H, Mohelnikova-Duchonova B, et al (2009). The association between glutathione S-transferase gene polymorphisms and pancreatic cancer in a central European Slavonic population. Mutat Res, 680, 78-81.   DOI   ScienceOn
23 O'Neil JD, Owen TJ, Wood VH, et al (2008). Epstein-Barr virusencoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J Gen Virol, 89, 2833-42.   DOI
24 Stuck AE, Rubenstein LZ ,Wieland D (1998). Bias in metaanalysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ, 316, 469; author reply 70-1.   DOI   ScienceOn
25 Tiwawech D, Srivatanakul P, Karalak A, et al (2005). Glutathione S-transferase M1 gene polymorphism in Thai nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 6, 270-5.
26 Wei YP, Long XD, Liu ZG, et al (2012). Genetic polymorphism of glutathione-S-transferase M1 and T1 in associated with carcinogenesis of hepatocellular carcinoma and nasopharyngeal carcinoma. Chin German J Clini Onc, 11, 138-41.   DOI
27 Zhuo XL, Cai L, Xiang ZL, et al (2009). GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis. J Exp Clin Cancer Res, 28, 46.